These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9850611)

  • 1. New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Primrose WU; Nahorski SR; Challiss RA
    Trends Pharmacol Sci; 1998 Nov; 19(11):467-75. PubMed ID: 9850611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
    Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR
    FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial calcium release in response to submaximal inositol 1,4,5-trisphosphate receptor activation.
    Missiaen L; Parys JB; De Smedt H; Oike M; Casteels R
    Mol Cell Endocrinol; 1994 Jan; 98(2):147-56. PubMed ID: 8143924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol 1,4,5-trisphosphate [correction of tris-phosphate] activation of inositol trisphosphate [correction of tris-phosphate] receptor Ca2+ channel by ligand tuning of Ca2+ inhibition.
    Mak DO; McBride S; Foskett JK
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15821-5. PubMed ID: 9861054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular magnesium and inositol 1,4,5-trisphosphate receptor: molecular mechanisms of interaction, physiology and pharmacology.
    Volpe P; Vezú L
    Magnes Res; 1993 Sep; 6(3):267-74. PubMed ID: 8292501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel Ins(1,4,5)P3 analogue 3-amino-3-deoxy-Ins(1,4,5)P3: a pH-dependent Ins(1,4,5)P3 receptor partial agonist in SH-SY5Y neuroblastoma cells.
    Kozikowski AP; Fauq AH; Wilcox RA; Challiss RA; Nahorski SR
    J Med Chem; 1994 Mar; 37(6):868-72. PubMed ID: 8145238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
    Lu PJ; Gou DM; Shieh WR; Chen CS
    Biochemistry; 1994 Sep; 33(38):11586-97. PubMed ID: 7918372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS; Beecroft MD; Riley AM; Jenkins DJ; Marwood RD; Taylor CW; Potter BV
    Biochemistry; 1997 Oct; 36(42):12780-90. PubMed ID: 9335535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of inositol 1,4,5-trisphosphate receptor.
    Yoshida Y; Imai S
    Jpn J Pharmacol; 1997 Jun; 74(2):125-37. PubMed ID: 9243320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational changes in plant Ins(1,4,5)P3 receptor on interaction with different myo-inositol trisphosphates and its effect on Ca2+ release from microsomal fraction and liposomes.
    Dasgupta S; Dasgupta D; Chatterjee A; Biswas S; Biswas BB
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):355-60. PubMed ID: 9020866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.
    Gregory RB; Hughes R; Riley AM; Potter BV; Wilcox RA; Barritt GJ
    Biochem J; 2004 Jul; 381(Pt 2):519-26. PubMed ID: 15169542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of inositol trisphosphate receptors.
    Taylor CW; Richardson A
    Pharmacol Ther; 1991; 51(1):97-137. PubMed ID: 1663251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of phosphatidylinositide transduction system in the rat spinal cord during aging.
    Igwe OJ; Filla MB
    Neuroscience; 1995 Dec; 69(4):1239-51. PubMed ID: 8848110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.